{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:01:25Z","timestamp":1760832085558,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3-5","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jsbmb.2011.12.002","type":"journal-article","created":{"date-parts":[[2011,12,30]],"date-time":"2011-12-30T10:21:07Z","timestamp":1325240467000},"page":"139-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Metabolism of the synthetic progestogen norethynodrel by human ketosteroid reductases of the aldo\u2013keto reductase superfamily"],"prefix":"10.1016","volume":"129","author":[{"given":"Yi","family":"Jin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor M.","family":"Penning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helenius J.","family":"Kloosterboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10\u201313","key":"10.1016\/j.jsbmb.2011.12.002_bib0005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2011.12.002_bib0010","first-page":"461","article-title":"Norethynodrel","volume":"21","year":"1979","journal-title":"IARC Monogr. Eval. Carcinog. Risk Chem. Hum."},{"issue":"2","key":"10.1016\/j.jsbmb.2011.12.002_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-3565(25)28270-2","article-title":"Metabolism of antifertility steroids. I. Norethynodrel","volume":"167","author":"Palmer","year":"1969","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jsbmb.2011.12.002_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0022-3565(25)29329-6","article-title":"Norethynodrel metabolites in human plasma and urine","volume":"183","author":"Cook","year":"1972","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.jsbmb.2011.12.002_bib0025","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1749-6632.1958.tb46794.x","article-title":"Effects of norethynodrel on the human endometrium","volume":"71","author":"Roland","year":"1958","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4 Suppl.","key":"10.1016\/j.jsbmb.2011.12.002_bib0030","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/cncr.2820710415","article-title":"The estrogenic activity of synthetic progestins used in oral contraceptives","volume":"71","author":"Jordan","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jsbmb.2011.12.002_bib0035","first-page":"441","article-title":"Norethisterone and norethisterone acetate","volume":"21","year":"1979","journal-title":"IARC Monogr. Eval. Carcinog. Risk Chem. Hum."},{"issue":"3","key":"10.1016\/j.jsbmb.2011.12.002_bib0040","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-5122(98)00059-0","article-title":"Tibolone: a review","volume":"30","author":"Albertazzi","year":"1998","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.jsbmb.2011.12.002_bib0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/dmd.30.2.106","article-title":"The in vivo human metabolism of tibolone","volume":"30","author":"Vos","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"1\u20135","key":"10.1016\/j.jsbmb.2011.12.002_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0960-0760(01)00044-9","article-title":"Tibolone: a steroid with a tissue-specific mode of action","volume":"76","author":"Kloosterboer","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.jsbmb.2011.12.002_bib0055","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1124\/mol.104.004515","article-title":"Tibolone is metabolized by the 3\u03b1\/3\u03b2-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo\u2013keto reductase 1C subfamily: inversion of stereospecificity with a \u03945(10)-3-ketosteroid","volume":"66","author":"Steckelbroeck","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.jsbmb.2011.12.002_bib0060","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1124\/jpet.105.091587","article-title":"Tibolone metabolism in human liver is catalyzed by 3\u03b1\/3\u03b2-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo\u2013keto reductase (AKR)1C subfamily","volume":"316","author":"Steckelbroeck","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Pt 1","key":"10.1016\/j.jsbmb.2011.12.002_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3510067","article-title":"Human 3\u03b1-hydroxysteroid dehydrogenase isoforms (AKR1C1\u2013AKR1C4) of the aldo\u2013keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones","volume":"351","author":"Penning","year":"2000","journal-title":"Biochem. J."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2011.12.002_bib0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2003.11.006","article-title":"Structure-function of human 3\u03b1-hydroxysteroid dehydrogenases: genes and proteins","volume":"215","author":"Penning","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"10.1016\/j.jsbmb.2011.12.002_bib0075","doi-asserted-by":"crossref","first-page":"10784","DOI":"10.1074\/jbc.M313308200","article-title":"Human cytosolic 3\u03b1-hydroxysteroid dehydrogenases of the aldo\u2013keto reductase superfamily display significant 3\u03b2-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action","volume":"279","author":"Steckelbroeck","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.jsbmb.2011.12.002_bib0080","doi-asserted-by":"crossref","first-page":"10013","DOI":"10.1074\/jbc.M809465200","article-title":"Human cytosolic hydroxysteroid dehydrogenases of the aldo\u2013keto reductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism","volume":"284","author":"Jin","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.jsbmb.2011.12.002_bib0085","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1021\/bi995085z","article-title":"Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7,8-dihydroxy-7,8-dihydrobenzo","volume":"38","author":"Burczynski","year":"1999","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.jsbmb.2011.12.002_bib0090","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0022-2836(03)00762-9","article-title":"Human 20\u03b1-hydroxysteroid dehydrogenase: crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids","volume":"331","author":"Couture","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"34","key":"10.1016\/j.jsbmb.2011.12.002_bib0095","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.1021\/bi010919a","article-title":"Crystal structure of human type III 3\u03b1-hydroxysteroid dehydrogenase\/bile acid binding protein complexed with NADP(+) and ursodeoxycholate","volume":"40","author":"Jin","year":"2001","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.jsbmb.2011.12.002_bib0100","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1158\/0008-5472.CAN-03-2847","article-title":"Crystal structures of prostaglandin D(2) 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin","volume":"64","author":"Lovering","year":"2004","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jsbmb.2011.12.002_bib0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.steroids.2005.12.002","article-title":"Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences","volume":"71","author":"Jin","year":"2006","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.jsbmb.2011.12.002_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J. Mol. Recognit."},{"issue":"6","key":"10.1016\/j.jsbmb.2011.12.002_bib0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0969-2126(97)00234-7","article-title":"Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3\u03b1-hydroxysteroid\/dihydrodiol dehydrogenase","volume":"5","author":"Bennett","year":"1997","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.jsbmb.2011.12.002_bib0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0039-128X(94)90047-7","article-title":"Early oral contraceptive history: norethynodrel is not a prohormone","volume":"59","author":"Edgren","year":"1994","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.jsbmb.2011.12.002_bib0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0010-7824(90)90093-B","article-title":"Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids","volume":"42","author":"Stanczyk","year":"1990","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.jsbmb.2011.12.002_bib0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1677\/joe.0.0620605","article-title":"Radioimmunoassay of synthetic progestogens, norethisterone and norgestrel","volume":"62","author":"Warren","year":"1974","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2011.12.002_bib0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/jrf.0.0490189","article-title":"Plasma concentrations of ethynyl oestradiol and norethindrone after oral administration to women","volume":"49","author":"Pasqualini","year":"1977","journal-title":"J. Reprod. Fertil."},{"issue":"3","key":"10.1016\/j.jsbmb.2011.12.002_bib0140","first-page":"385","article-title":"Disappearance in plasma and tissue uptake of radioactivity after an intravenous injection of (6,7-3H) norethynodrel in women","volume":"66","author":"Laumas","year":"1971","journal-title":"Acta Endocrinol. (Copenh.)"},{"issue":"8","key":"10.1016\/j.jsbmb.2011.12.002_bib0145","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0002-9378(76)90689-X","article-title":"Metabolism of oral contraceptive drugs. The formation and disappearance of metabolites of norethindrone and mestranol after intravenous and oral administration","volume":"126","author":"Mills","year":"1976","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"43","key":"10.1016\/j.jsbmb.2011.12.002_bib0150","doi-asserted-by":"crossref","first-page":"13054","DOI":"10.1021\/bi060591r","article-title":"Multiple steps determine the overall rate of the reduction of 5\u03b1-dihydrotestosterone catalyzed by human type 3 3\u03b1-hydroxysteroid dehydrogenase: implications for the elimination of androgens","volume":"45","author":"Jin","year":"2006","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.jsbmb.2011.12.002_bib0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/BJ20101804","article-title":"Stereospecific reduction of 5\u03b2-reduced steroids by human ketosteroid reductases of the AKR (aldo\u2013keto reductase) superfamily: role of AKR1C1\u2013AKR1C4 in the metabolism of testosterone and progesterone via the 5\u03b2-reductase pathway","volume":"437","author":"Jin","year":"2011","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.jsbmb.2011.12.002_bib0160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9378(79)90467-8","article-title":"Accumulation of norethindrone and individual metabolites in human plasma during short- and long-term administration of a contraceptive dosage","volume":"133","author":"Braselton","year":"1979","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.jsbmb.2011.12.002_bib0165","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0022-4731(90)90196-Y","article-title":"In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium","volume":"35","author":"Markiewicz","year":"1990","journal-title":"J. Steroid Biochem."},{"issue":"1","key":"10.1016\/j.jsbmb.2011.12.002_bib0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0039-128X(02)00112-5","article-title":"Receptor profiling and endocrine interactions of tibolone","volume":"68","author":"de Gooyer","year":"2003","journal-title":"Steroids"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076011002445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076011002445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:38:34Z","timestamp":1760744314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076011002445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":34,"journal-issue":{"issue":"3-5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0960076011002445"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2011.12.002","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism of the synthetic progestogen norethynodrel by human ketosteroid reductases of the aldo\u2013keto reductase superfamily","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2011.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}